Rebekka Schneider
@rschneiderlab
physician-scientist passionate about research on #MDS, #MPNsm, #fibrosis; CKD; #bonemarrowniche. #oncode; #ERCStg/COG/PoC; twin mom
ID:899286741990998017
20-08-2017 15:07:22
1,0K Tweets
1,7K Followers
943 Following
Congratulations Ralf H. Adams! Can’t wait to see and read the work arising from this ERCAdG- super exciting!
Check out our work on using patient-derived iPSC to study megakaryocytes in MPN and myelofibrosis! cell.com/stem-cell-repo…
Which all would have not been possible without great supervision and amazing collaborators! Martin Zenke, Rebekka Schneider , Miguel Castilho and many more!
🔥Check out the exciting PhD project in our ERC funded research program 'RewindMF' in our fantastic and fun team
RWTH Aachen
Uniklinik RWTH AC jobrxiv.org/job/rwth-aache…. Please RT and share the news in your network! Can't wait to hear from you
A quick rundown of combination partners with HMA that “failed” in HR-MDS in randomized studies: APR-246 (epranetopopt), pevonedistat, lenalidomide, magrolimab, TPO agonists, many HDAC inhibitors, now sabatolimab. Amer Zeidan MBBS,MHS عامر زيدان Mikkael A. Sekeres MD, MS & #MDSsm colleagues - missing any?
Discouraging news today: #MDSsm sabatolimab+azacitidine STIMULUS-MDS2 trial was negative (no OS benefit vs aza alone.) It has been so long since there was good news in HR MDS. If venetoclax+HMA trial is negative will Pharma give up on HR-MDS as too hard?🙁pharmaphorum.com/news/novartis-…
Wir laden alle Kollegen und Interessierten inner-und außerhalb des #cioabcd herzlich zu unserem mittlerweile 12. Aachen-Düsseldorf-Mönchengladbacher Forum Hämatologie 2024 ein. Uniklinik RWTH AC Uniklinik Düsseldorf GSG-MPN